Final Report. Acute oral toxicity study in Wistar rats. Mr. S. Haribabu, B Tech (Biotech), MSc
|
|
- Tabitha Singleton
- 5 years ago
- Views:
Transcription
1 Study Title Test Item Study Director Sponsor Study Monitor Test Facility Acute oral toxicity study in Wistar rats Nualgi Nano Nutrients Mr. S. Haribabu, B Tech (Biotech), MSc Nualgi Nano Biotech Co 651, 11 th Main Road V Block, Jayanagar Bengaluru Mr. Sunil Nanda Plot 18-19, Ganesh Nagar, Asisi Nagar Madhavaram, Chennai Tamil Nadu India. Study Number 161/001 Regulatory Guideline OECD Guidelines for Testing of Chemicals, 423 (adopted on 17 th December, 2001). Report Issued 01 October 2015 Total Number of Pages 18...committed to scientific and service excellence Page 1
2 CONTENTS Contents... 2 Study Director Authentication Statement... 3 Quality Assurance Statement... 4 Test Facility Management Statement... 5 Peer Review Statement... 6 Summary... 7 Introduction... 8 Objective... 9 Study Dates... 9 Test Item Details... 9 Test System Test Method Observations Data Evaluation Results Conclusion References Responsible Personnel Study Plan Amendment Study Plan Deviation Archive Statement Distribution of Reports Appendix Page 2 of 18 -
3 STUDY DIRECTOR AUTHENTICATION STATEMENT Nualgi Nano Nutrients: Acute oral toxicity study in Wistar rats This study was performed in accordance to the agreed Study Plan, One amendment and with GLR Laboratories Pvt Ltd Standard Operating Procedures, unless otherwise stated, and the study objective was achieved. I accept responsibility for the work and generated data, that are scientifically acceptable and valid; and this report provides a true and accurate record of the results obtained. This study was performed based on the OECD Principles of Good Laboratory Practice * ENV/MC/CHEM (98)17 (Revised 1997, issued January 1998). Mr. S. Haribabu, B Tech (Biotech), MSc Study Director GLR Laboratories Pvt Ltd Study completion date * With the exception of the identity and composition of the test item, which were the responsibilities of the sponsor. - Page 3 of 18 -
4 QUALITY ASSURANCE STATEMENT Final Report This study report has been reviewed by the Quality Assurance Unit of GLR Laboratories Pvt Ltd, based on the OECD Principles of GLP, Study Plan, Amendment, Raw Data and applicable Standard Operating Procedures. This statement confirms that the study report accurately reflects raw data. The summary of inspections performed during the course of study is as follows: S. No Type of Inspection Date of Inspection Phase(s) of Study Inspected Date of Reporting to Management, Study Director (Inspection Report No.) 1 Study Based Inspection 06 August 2015 Draft Study Plan 06 August 2015 (SBI/161/001/001) 2 Study Based Inspection 07 August 2015 Definitive Study Plan 07 August 2015 (SBI/161/001/002) 3 Study Based Inspection 18 August 2015 Test Item Administration 18 August 2015 (SBI/161/001/003) 4 Study Based Inspection 15 September 2015 Definitive Study Plan Amendment 15 September 2015 (SBI/161/001/004) 5 Study Based Inspection 30 September 2015 Draft Report 30 September 2015 (SBI/161/001/005) 6 Study Based Inspection 01 October 2015 Final Report 01 October 2015 (SBI/161/001/006) Dr. G. Velmani, M Pharm, PhD Executive-Quality Assurance GLR Laboratories Pvt Ltd Date - Page 4 of 18 -
5 TEST FACILITY MANAGEMENT STATEMENT Final Report Nualgi Nano Nutrients: Acute oral toxicity study in Wistar rats This is to certify that the GLR test facility management appointed the Study Director for this study and provided him with all necessary facilities and resources for proper conduct of this study, both in terms of GLP and scientific integrity. Dr. S. S. Murugan, PhD Test Facility Management GLR Laboratories Pvt Ltd Date - Page 5 of 18 -
6 PEER REVIEW STATEMENT Final Report This is to certify that I have reviewed the raw data and report along with the study director and agree with the scientific conclusions made. Dr. T S Kumaravel, MD, PhD, DABT American Board Certified and UK Registered Toxicologist GLR Laboratories Pvt Ltd Date - Page 6 of 18 -
7 SUMMARY This study was performed to determine the acute toxicity effect of Nualgi Nano Nutrients, when administered as a single oral dose to rats, followed by an observation period of 14 days. A stepwise procedure using 3 female animals per step was used in this study to assess the acute toxicity of the test item as described in the OECD guidelines for testing of chemicals, 423. The starting dose was 300 mg/kg body weight. Test item was mixed with distilled water to achieve the desired concentration. All animals received a single dose of the test item by oral route of administration after being fasted for approximately 15 to 16 hours, but with free access to water. A dose volume of 10 ml/kg b.w. was used. Food was supplied approximately 3 h to 4 h after test item administration. The results are summarised in the table below: Step Date Dose (mg/kg) Number of animals Number of moribund or dead animals Subsequent action 1 18 August females 0 Proceeded to Step August females 0 Proceeded to Step September females 0 Proceeded to Step September females 0 Stop No mortality and morbidity were observed in any of the animals administered with the test item. In all the steps, animals were in somnolence condition with decreased motor activity. None of the animals exhibit gross lesions related to test item administration. Increase in body weight was observed in all the treated animals at the end of the each step of the experiment. Based on the results obtained, it is concluded that, Nualgi Nano Nutrients, falls under Category 5 or unclassified according to the Globally Harmonized System (GHS) for the classification of chemicals. The cut off LD 50 value is greater than 5000 mg/kg. - Page 7 of 18 -
8 INTRODUCTION Acute oral toxicity is the study of adverse effects of a chemical that result either from a single oral exposure or from multiple exposures within 24 hours. Acute oral toxicity provides general information on health hazards likely to arise from an acute exposure. An acute toxicity study might be an initial step in establishing a dosage regimen in sub acute/sub chronic and other studies and may provide information on the mode of toxic action of a substance by the intended clinical exposure route. The test selection and methods used in this study are based on the following guideline: 1. Organization for Economic Co-operation and Development Guidelines for Testing of Chemicals (Sec. 4, No.423, Acute Toxic Class Method, Adopted 17 th December, 2001). - Page 8 of 18 -
9 OBJECTIVE To determine the acute toxic potential of test item when administered by a single oral dose to rats, followed by an observation period of 14 days. STUDY DATES Study Start Date 07 August 2015 Experiment Start Date 18 August 2015 (first dosing date) Experiment Completion Date 21 September 2015 The study completion date is the date the final report is signed by the Study Director. This study was performed in line with agreed study plan and one amendment. TEST ITEM DETAILS The test item for this study was Nualgi Nano Nutrients. It was received at GLR on 21 July 2015 and stored at Room temperature (20-30) C. The following test item information provided by the Sponsor, are considered an adequate description of the characterisation, purity and stability of the test item. Name Appearance Colour Nualgi Nano Nutrients Liquid Greenish Batch No Formulation/Composition Nano nutrients mixture of primary, Secondary, Micro CO, Si Manufacture Date 03 July 2015 Expiry Date Chemical Name CAS No Molecular Formula Molecular Weight Solubility ph 8.01 Photo-Stability 3 years from manufacturing Nano nutrients Not Applicable Not Applicable Not Applicable Soluble in water Yes - Page 9 of 18 -
10 Determinations of stability and characteristics of the test item were the responsibility of the Sponsor. The test item was handled with necessary protective clothing and all recommended safety measures were followed. TEST SYSTEM Species Strain Age Sex Source Rattus norvegicus (rat) Wistar 8-12 weeks Female Sainath Agencies, Hyderabad, India. This supplier is approved by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Government of India for breeding laboratory animals. Weight Range at the start of experiment (g) Number of animals used Step Step Step Step Twelve (Three animals/step) Acclimatization period Step 1 6 days Justification for animal use Step 2 Step 3 Step 4 8 days 8 days 12 days Rats were selected because there is a large volume of background data on this species. Specified in OECD Guidelines for Testing of Chemicals, 423 standards, as an appropriate test to evaluate the oral toxicity of test item and recommended by various regulatory authorities. The test system was approved by the GLR Laboratories Pvt Ltd s Institutional Animal Ethics Committee (IAEC). - Page 10 of 18 -
11 ANIMAL HUSBANDRY Final Report Location Test room 2 Test room temperature C Relative humidity 35-68% Housing Method of identification Diet Water Bedding material Photo period Contaminants Personnel Selection of animals Animals were housed in groups of three in standard polypropylene cages with stainless steel top grill. Animals were identified using cage cards indicating cage no., study no., species name, strain, animal no., sex, age/bodyweight, group, dose, signature and individual marking. Rat pellet feed (Amrut) Purified drinking water was provided ad libitum Sterilized paddy husk 12 h light and 12 h dark cycle Contaminants reasonably expected in feed and water supplied was not believed to influence the outcome of the study. Associates involved in this study were appropriately qualified and trained. Only healthy, previously unused animals were selected for this study. TEST METHOD Preparation of the test item The test item was mixed in distilled water to achieve the desired concentrations. Doses were prepared and administered immediately. The details of the doses and the concentration of the dosing solutions are given below: Date Dose Concentration (mg/kg b.w.) a Test item (mg) Volume of vehicle made up to (ml) Concentration of dosing solution (mg/ml) b 18 August August September September b.w., body weight a All treatment doses expressed as nominal dose administered b All dosing preparations expressed as nominal concentrations - Page 11 of 18 -
12 Test Procedure A stepwise procedure using 3 female animals per step was used in this study to assess the acute toxicity of the test item as described in the OECD guidelines for testing of chemicals, number 423. In the lack of information, a starting dose of 300 mg/kg b.w. was selected for Step 1. The test procedure followed the attached scheme described in Appendix 1. All the animals received a single dose of the test item by oral route of administration, after being fasted for approximately 15 to 16 hours, but with free access to water. Food was supplied approximately 3 h to 4 h after test item administration. A dose volume of 10 ml/kg was used. Individual dose volumes are given in Table 3. Based on the outcomes of the previous step, further steps were carried out. OBSERVATIONS Mortality & Morbidity All the animals were observed for mortality and morbidity for a period of fourteen days following the test item administration. If no mortality or morbidity is observed at a particular experimental step at the end of Day 1, the next steps were started based on the scientific judgement of the Study Director. Body Weight Recording Body weights of each animal were recorded prior to the test item administration (Day 0) and on Days 7 and 14 of the particular experimental step. Clinical Observation Clinical observations were performed to look for signs of ill health or overt toxicity during the first 30 minutes and at approximately 1, 2, 3 and 4 h after dose administration on Day 0 and daily during days Any abnormalities of appearance or behaviour or other signs of reaction to treatment or ill health were recorded and a detailed individual record was maintained of the clinical condition of each animal. Gross Pathology Examination All the survival animals were necropsied at the end of 14-day observation period and subjected to gross pathology. - Page 12 of 18 -
13 DATA EVALUATION Based on the observations the test item were categorised as per the Globally Harmonized Classification System and appropriate cut off LD 50 range determined. RESULTS Mortality & Morbidity The results of mortality and morbidity; and various experimental steps used in this study are given in Table 1. Body Weight Recording Body weights of each animal recorded prior to the test item administration (Day 0) and on Day 7 and 14 of the experiment are presented in Table 2. Clinical Observation Clinical signs were observed in all the steps and the signs are presented in Table 1. Gross Pathology Examination Gross pathology observations of the animals at various steps are presented in Table 1. CONCLUSION Based on the results obtained, it is concluded that, Nualgi Nano Nutrients, falls under Category 5 or unclassified according to the Globally Harmonized System (GHS) for the classification of chemicals. The cut off LD 50 value is greater than 5000 mg/kg. - Page 13 of 18 -
14 REFERENCES 1. Organization for Economic Co-operation and Development (OECD) Guidelines for Testing of Chemicals (Sec. 4, No.423, Acute Toxic Class Method, Adopted 17 th December, 2001). 2. OECD Principles of Good laboratory Practice. OECD Environmental Health and Safety Publications, Series on Principles of Good Laboratory Practice and Compliance Monitoring No. 1. ENV/MC/CHEM (98)17. - Page 14 of 18 -
15 Table 1: Results of Mortality & Morbidity; Clinical signs and Gross pathology Steps Date Dose concentration Animal No. Clinical Signs Mortality & Morbidity Day of Necropsy Gross Pathology 1 18 August mg/kg 2 20 August mg/kg 1 NAD All animals were in somnolence condition with Nil 2 decreased motor activity following test item 01 September 2015 NAD administration on day 0. 3 NAD 4 NAD All animals were in somnolence condition with 5 decreased motor activity following test item Nil 03 September 2015 NAD administration on day 0. 6 NAD 3 03 September mg/kg 7 NAD All animals were in somnolence condition with 8 decreased motor activity following test item Nil 17 September 2015 NAD administration up to day 2. 9 NAD 10 NAD 4 07 September mg/kg 11 All animals were in somnolence condition with decreased motor activity following test item Nil 21 September 2015 NAD administration up to day NAD NAD - No Abnormality Detected; - Page 15 of 18 -
16 Table 2: Individual body weights (g) Step (mg/kg b.w.) 1 (300) 2 (300) 3 (2000) 4 (2000) Animal No. Day 0 Day 7 Day 14 Increase in body weight at the end of the experiment Table 3: Dosing time and volume administered Step Date Animal No. Dosing Time Total Dose Volume (ml) August am August am September am September am Page 16 of 18 -
17 RESPONSIBLE PERSONNEL Mr. S. Haribabu, B Tech (Biotech), MSc Dr. R. M. Balaje, MVSc Mr. M. Vasanthan, M Tech (Biotech) Study Director Animal House In-charge Study Scientist STUDY PLAN AMENDMENT One amendment was made to modify the test item name from Nualgi Foliar Nano Nutrients to Nualgi Nano Nutrients. STUDY PLAN DEVIATION No deviations from the study plan were found during the conduct of the study. ARCHIVE STATEMENT All primary data, or authenticated copies thereof, slides (if applicable), tissue specimens (if applicable), a sample test item and the final report will be retained, for a period of 9 years, in the archives after issue of the final report. At the end of the specified archive period the Sponsor will be contacted to determine whether the data should be returned, retained or destroyed on their behalf. Sponsors will be notified of the financial implications of each of these options at that time. DISTRIBUTION OF REPORTS Two originals of the study report are prepared and distributed as mentioned below: a. One Copy - Sponsor. b. One Copy - Archive. - Page 17 of 18 -
18 APPENDIX 1 Taken from OECD Guidelines for Testing of Chemicals, 423 (adopted on 17 th December, 2001) - Page 18 of 18 -
Final Report. Acute dermal toxicity study in Wistar rats. Mr. M. Vasanthan, M Tech (Biotech)
Study Title Test Item Study Director Sponsor Study Monitor Test Facility Acute dermal toxicity study in Wistar rats Nualgi Nano Nutrients Mr. M. Vasanthan, M Tech (Biotech) Nualgi Nano Biotech Co 651,
More informationSHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH. ACUTE ORAL TOXICITY STUDY IN RATS WITH Cry 1 C a 1 PROTEIN
ACUTE ORAL TOXICITY STUDY IN RATS WITH Cry 1 C a 1 PROTEIN REPORT FOR METAHELIX LIFE SCIENCES PVT. LTD., PLOT NO.-3, KIADB 4 TH PHASE, BOMMASANDRA, BANGALORE-500 099, INDIA. GUIDELINES DBT Guidelines TEST
More informationSHRIRAM INSTITUTE FOR INDUSTRIAL RESEARCH
IN RATS SUB CHRONIC ORAL TOXICITY WITH NHH 44 Bt-COTTON SEEDS Report for: UNIVERSITY OF AGRICULTURAL SCIENCES AGRICULTURAL RESEARCH STATION DHARWAD-580007 KARNATAKA Guidelines: DBT, Guidelines for Toxicity
More informationAN ACUTE ORAL TOXICITY STUDY IN RATS WITH ADVANTRA Z
AN ACUTE ORAL TOXICITY STUDY IN RATS WITH ADVANTRA Z AMENDED FINAL REPORT Author Deborah A Douds, M.S. Original Study Completion Date July 8, 1997 Amended Study Completion Date November 19, 1997 Performing
More informationPRODUCT STUDY TITLE DATA REQUIREMENT AUTHOR STUDY COMPLETED ON PERFORMING LABORATORY LABORATORY STUDY NUMBER
Product Safety Laboratories 2394 Highway 130 Dayton, NJ 08810 Tel: 732.438.5100 Fax: 732.355.3275 e-mail: PSL@productsafetylabs.com PRODUCT Stalosan F STUDY TITLE Acute Dermal Toxicity Study in Rats -
More informationFINAL REPORT STUDY TITLE. EVALUATION OF APHRODISIAC ACTIVITY OF VigRx IN MALE ALBINO WISTAR RATS. Report No.: R401.
FINAL REPORT STUDY TITLE EVALUATION OF APHRODISIAC ACTIVITY OF IN MALE ALBINO WISTAR RATS STUDY DIRECTOR Dr. Amit A, Ph.D. SPONSOR AIBMR Life Sciences, Inc. 4117, South Meridian, Puyallup, WA 98373 CONTENTS
More informationPacificBeam SHELLIII/PB-SHELL3: ACUTE DERMAL IRRITATION IN THE RABBIT PROJECT NUMBER: 2533/0014 AUTHOR:
PAGE 1 OF 14 PAGES PacificBeam SHELLIII/PB-SHELL3: ACUTE DERMAL IRRITATION IN THE RABBIT PROJECT NUMBER: 2533/0014 AUTHOR: A Sanders STUDY SPONSOR: M.I.C.(Medical Intelligence Corporation) Co., Ltd. 2-2-15
More informationAcute Oral Toxicity Study in Rats with Argentyn 23 (EPA/OECD Guidelines) Study Title. Monica M. Vegarra, BS. Sponsor
Note: This study was done using our Professional strength 23 ppm product (Argentyn 23), therefore making Sovereign Silver at 10 ppm, 2.3 times safer. Conclusion on page 6 shows the product to be non-toxic
More informationPage 1132
Page 1131 Page 1132 Page 1133 Page 1134 Page 1135 Huntingdon Life Sciences 03-6140 Page 6. Final Report TABLE OF CONTENTS Page 1136 COVER PAGE...1 GLP STATEMENT...2 SIGNATURE PAGE...3 QUALITY ASSURANCE
More informationC.16. HONEYBEES - AC UTE ORAL TOXICITY TEST. This acute toxicity test method is a replicate of the OECD TG 213 (1998).
C.16. HONEYBEES - AC UTE ORAL TOXICITY TEST 1. METHOD This acute toxicity test method is a replicate of the OECD TG 213 (1998). 1.1 INTRODUCTION This toxicity test is a laboratory method, designed to assess
More informationGuidance on the GLP Requirements for Peer Review of Histopathology Advisory Document
GLP Roundtable 2014 Guidance on the GLP Requirements for Peer Review of Histopathology Advisory Document Dr. Elisabeth Klenke, Head Preclinical Review and GLP Monitoring Compliance Unit Swissmedic Swiss
More informationTERMS AND CONDITIONS NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY
TERMS AND CONDITIONS OF NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY FOR OBTAINING AND MAINTAINING ITS GLP CERTIFICATION BY A TEST FACILITY Document No.GLP-101 Version/Issue
More informationPlease find enclosed Dosimetry Service Licence No which replaces Dosimetry Service Licence No
Directorate of Nuclear Substance Regulation Telephone: 1 (888) 229-2672 April 12, 2017 Licence Number Christopher Passmore Landauer Inc. 2 Science Road Glenwood, IL 60425-1586 Subject: Dosimetry Service
More informationGLP VIRUCIDAL TESTING OF ZEROMOLD PLUS FOR HIV-1
Southwest Research Institute Page 1 of 8 Microencapsulation and Nanomaterials Department Amended Final Report: GLP Virucidal Testing of ZeroMold Plus for HIV-1 Protocol No.: GLP-SP-239 FINAL REPORT STUDY
More informationModule 34: Legal aspects, ADI and GRAS status of food additives
Paper No.: 13 Paper Title: FOOD ADDITIVES Module 34: Legal aspects, ADI and GRAS status of food additives 34.1 Legal Aspects of Food Additives The data provided by Joint Expert Committee on Food Additives
More informationSpecific Accreditation Guidance OECD GLP
Specific Accreditation Guidance OECD GLP Information for GLP Study Sponsors January 2018 Copyright National Association of Testing Authorities, Australia 2013 This publication is protected by copyright
More informationFood Fortification Regulations, 2016 (Gazetted on 24 October, 2016) ARRANGEMENT OF SECTIONS PART I PRELIMINARY
Statutory Instrument 120 of 2016 Food Fortification Regulations, 2016 (Gazetted on 24 October, 2016) [Cap 15:05 Section 1 Title 2 Interpretation ARRANGEMENT OF SECTIONS PART I PRELIMINARY 3 Inspection
More informationResidue Chemistry Studies for Veterinary Drugs. Human Food Safety Assessment. Presentation Topic. Improving residue chemistry submissions
Residue Chemistry Studies for Veterinary Drugs Julia A. Oriani, Ph.D. Food and Drug Administration Center for Veterinary Medicine Division of Human Food Safety Human Food Safety Assessment Risk = Hazard
More informationControl of Substances Hazardous to Health (COSHH) Regulations 2002
Control of Substances Hazardous to Health (COSHH) Regulations 2002 1. Purpose This document provides guidance to staff on how to comply with the COSHH Regulations 2002 (as amended) and in particular informs
More informationAcute Oral Toxicity Study on
Acute Oral Toxicity Study on MAKARDHWAJ RASAYAN TABLET OF Sponsor Study Centre: VIRGO UAP PHARMA PVT.LTD. PHARMACOLOGY LABORATORY MAHAGUJARAT IND.ESTATE, SDM CENRE FOR RESEARCH IN PLOT NO. 423/98-B. AYURVEDA
More informationAcute Oral Toxicity Study on
Acute Oral Toxicity Study on SOBEREX CAPSULE OF Sponsor Study Centre: VIRGO UAP PHARMA PVT.LTD. PHARMACOLOGY LABORATORY MAHAGUJARAT IND.ESTATE, SDM CENRE FOR RESEARCH IN PLOT NO. 423/98-B. AYURVEDA AND
More informationMB Research Laboratories
MB Research Laboratories 1765 Wentz Road P.O. Box 178 Spinnerstown, PA 18968 phone (215) 536-4110 fax (215) 536-1816 Study Title : Single Dose Oral Toxicity in Rats Test Article : ZEOLITE PURE, Lot/Batch#
More informationOECD GUIDELINE FOR TESTING OF CHEMICALS
OECD/OCDE 420 Adopted: 17 th December 2001 OECD GUIDELINE FOR TESTING OF CHEMICALS Acute Oral Toxicity Fixed Dose Procedure INTRODUCTION 1. OECD Guidelines for the Testing of Chemicals are periodically
More informationGLP in the European Union Ecolabel detergents, GLP and accreditation
GLP in the European Union Ecolabel detergents, GLP and accreditation Maik Schmahl Brussels, 25/03/2010 Chemicals Unit Outline What is GLP? How has it developed? The role of the Member States, the European
More informationAn Oral Acute Toxicity Study of Extracts from Salvia Splendens (Scarlet Sage) As Per OECD Guidelines 423
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationControlled Substances Program. For Academic Units
Brigham Young University Page 1 Provo, Utah Controlled Substances Program For Academic Units Last Revised: November 30, 2009 Brigham Young University Page 2 TABLE OF CONTENTS Section Title Page 1.0 Overview
More informationFood additives. FAO guidelines on the structure and content of the document called "Chemical and Technical Assessment (CTA)" Rome, February 2003
FAO Joint Secretariat to JECFA Joint FAO/WHO Expert Committee on Food Additives Food additives FAO guidelines on the structure and content of the document called "Chemical and Technical Assessment (CTA)"
More informationAcute Toxicity Profiling of Siddha Drug Oma Kudineer in Wistar Rats
Human Journals Research Article September 2017 Vol.:10, Issue:2 All rights are reserved by Dr. D. S. LAVANYA et al. Acute Toxicity Profiling of Siddha Drug Oma Kudineer in Wistar Rats Keywords: Oma kudineer,
More informationNew regulatory requirements DPCS Regulations 2017
New regulatory requirements DPCS Regulations 2017 Prescribers and pharmacists May 2017 Table of Contents Explanatory notes... 1 Clarifying the meaning of key terms... 1 Chart instructions and prescriptions...
More informationC.17. HONEYBEES - AC UTE CONTACT TOXICITY TEST. This acute toxicity test method is a replicate of the OECD TG 214 (1998).
C.17. HONEYBEES - AC UTE CONTACT TOXICITY TEST 1. METHOD This acute toxicity test method is a replicate of the OECD TG 214 (1998). 1.1 INTRODUCTION This toxicity test is a laboratory method, designed to
More informationEPA REGULATORY UPDATE
SOCIETY OF QUALITY ASSURANCE REGULATORY FORUM EPA REGULATORY UPDATE Linthicum Heights, Maryland January 24, 2008 Robert Cypher United States Environmental Protection Agency 2/13/2008 SQA Baltimore 1 ANY
More informationFINAL REPORT "ACUTE ORAL TOXICITY IN RATS - FIXED DOSE" F R.1
grupo 4- ',.-,..., ec f::::::~~~yzer \.,\.. FNAL REPORT "ACUTE ORAL TOXCTY N RATS - FXED DOSE" Sponsor Address: of Study: Ecolyzer Protocol: Receipt of Subst. Test: Start of Trial: End of Trial: Emission
More informationGUIDE TO REGISTER HOMEOPATHIC PRODUCTS FOR VETERINARY USE
CAMEVET PROCEEDINGS II REVIEW DATE in BRAZIL: HOMEOPATHIC COMMISSION - SINDAN August 18, 2016 GUIDE TO REGISTER HOMEOPATHIC PRODUCTS FOR VETERINARY USE SÃO PAULO, BRAZIL August 2016 Page 2 of 9 GUIDE TO
More informationAs Introduced. 132nd General Assembly Regular Session H. B. No
132nd General Assembly Regular Session H. B. No. 560 2017-2018 Representative Lanese A B I L L To amend sections 923.41, 923.48, and 923.51 of the Revised Code to prohibit pet food from containing remains
More informationSingle market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations Brussels,
More informationIonising Radiation Policy
Ionising Radiation Policy CONTENTS 1. University Policy. 2. Procedures / Guidance. 2.1 Responsibilities of the Deans of Schools and/or Heads of Departments 2.2 Radiation Protection Advisor / Radiation
More informationDivision of Research University Policy
Division of Research University Policy SUBJECT: Effective Date: Policy Number: SATELLITE ANIMAL HOUSING FACILITIES June 24, 2016 Supersedes: August 22, 2014 1 5 Responsible Authorities: Vice President,
More informationAll member States were represented, except Bulgaria and Czech Republic
SANCO D1(2007)D/412302 SUMMARY RECORD OF THE STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH HELD IN BRUSSELS ON 5 OCTOBER 2007 SECTION TOXICOLOGICAL SAFETY OF THE FOOD CHAIN President : Mrs Patricia
More informationNHS: 2005 PCA(D)11 abcdefghijklm
NHS: 2005 PCA(D)11 abcdefghijklm = eé~äíü=aéé~êíãéåí= = aáêéåíçê~íé=çñ=mêáã~êó=`~êé=~åç=`çããìåáíó=`~êé= = mêáã~êó=`~êé=aáîáëáçå= = pí=^åçêéïdë=eçìëé= = oéöéåí=oç~ç= = bafk_rode= = ben=pad= Dear Colleague
More informationFlorida A & M University Office of Human Resources INTERNAL OPERATING PROCEDURE. Procedure No. HR-7000
Subject: Alcohol and Drug Testing Policy Florida A & M University Office of Human Resources INTERNAL OPERATING PROCEDURE Procedure No. HR-7000 Authority: Florida Statutes 1001.74; Chapter 112.0455, Florida
More informationRESEARCH WITH HIGHLY PATHOGENIC AVIAN INFLUENZA H5N1
Page 1 of 8 RESEARCH WITH HIGHLY PATHOGENIC AVIAN INFLUENZA H5N1 The University of Pittsburgh has developed guidelines to establish a system of education and safeguards to ensure compliance with both the
More informationMEDICNES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF HERBAL MEDICINAL PRODUCTS IN THE GAMBIA
MEDICNES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF HERBAL MEDICINAL PRODUCTS IN THE GAMBIA Document No.: MCA/HMPG/17/12/01 Date of Adoption: 20 th January 2017 Date of Issue: 25 th July 2017 Version
More informationyzer :f::::::\\ \\.~::::::: FINAL REPORT "ACUTE ORAL TOXICITY IN RATS - FIXED DOSE" F R.1 Unreported
grupo # yzer, ec. :f::::::\\ \\.~:::::::..... FNAL REPORT "ACUTE ORAL TOXCTY N RATS - FXED DOSE" Sponsor of Study: Address: Ecolyzer Protocol: Receipt of Subst. Test: Start of Trial: End of Trial: Emission
More informationHOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) DRAFT (12/08) POINTS TO CONSIDER ON STABILITY TESTING OF HOMEOPATHIC MEDICINAL PRODUCTS
HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) DRAFT (12/08) POINTS TO CONSIDER ON STABILITY TESTING OF HOMEOPATHIC MEDICINAL PRODUCTS DISCUSSION IN THE SUBGROUP STABILITY April / May 2008 DISCUSSION
More informationPATIENT GROUP DIRECTION PROCEDURE
PATIENT GROUP DIRECTION PROCEDURE Date approved 2 October 2015 Version 3 Approved by Yvette Oade, Chief Medical Officer Procedure Lead Clinical Governance Lead - Medicines Management Procedure Author Karen
More information2017 FDA Food Code. FDA/CFSAN Retail Food Policy Team
2017 FDA Food Code FDA/CFSAN Retail Food Policy Team The FDA Food Code: Provides FDA s current thinking on food safety and sanitation in the retail food sector. Can be uniformly adopted as a statute, regulation
More informationComparability and quality of experimental data under different quality systems. S. Caroli Istituto Superiore di Sanità Rome
Comparability and quality of experimental data under different quality systems S. Caroli Istituto Superiore di Sanità Rome Programme of this presentation Part I. Background information Part II. Key aspects
More informationGCC Guide for Control on Imported Foods
Secretariat General of the Gulf Cooperation Council The Cooperation Council for the Arab States of the Gulf GCC GCC Guide for Control on Imported Foods Dr. BANDAR M. ALODIANI April 2018 1 Introduction:
More informationNUTRACEUTICALS / NATURAL PRODUCT
NUTRACEUTICALS / NATURAL PRODUCT: HOW TO BRING THEM TO HIGHER CLAIMS @ BIO-BORNEO-2015 Dr. RAVI K. B B.V.Sc & AH., M.V.Sc (ARGO). COO and Test Facility Management MyBioscience Lab Sdn. Bhd., Melaka, Malaysia.
More informationDispensing and administration of emergency opioid antagonist without a
68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies
More informationSTATE OF IDAHO BOARD OF DENTISTRY
STATE OF IDAHO BOARD OF DENTISTRY APPLICATION FOR ANESTHESIA PERMIT Dentists or dental specialists actively licensed in the state of Idaho cannot use conscious sedation or general anesthesia/deep sedation
More informationCOMMISSION REGULATION (EU)
11.3.2011 Official Journal of the European Union L 64/15 COMMISSION REGULATION (EU) No 234/2011 of 10 March 2011 implementing Regulation (EC) No 1331/2008 of the European Parliament and of the Council
More informationUNTHSC. Institutional Animal Care and Use Committee
Institutional Animal Care and Use Committee Title: Food and Water Restriction Document #: 028 Version #: 01 UNTHSC Approved by IACUC Date: May 27, 2014 A. BACKGROUND INFORMATION a. Food or fluid restriction
More informationUse of Controlled Substances in Research.
3341-7-09 Use of Controlled Substances in Research. Applicability Faculty and staff who hold federal Drug Enforcement Administration (DEA) licenses to use controlled substances for research purposes. Responsible
More informationAUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE WITH QUALITY MANAGEMENT SYSTEM FOR PATIENT GROUP DIRECTIONS
AUDIT TOOL FOR DISPENSING SERVICES COMPILED BY: Lynn Morrison ISSUE 1 CHECKED BY: Colette Byrne NUMBER: ISSUE DATE: 01.12.07 SUPERSEDES: NEW REVIEW DATE: 01.12.09 AUDIT TOOL FOR SELF INSPECTION OF COMPLIANCE
More informationNHS: 2004 PCA(D)9 abcdefghijklm
NHS: 2004 PCA(D)9 abcdefghijklm Health Department Primary Care Division St Andrew's House Directorate of Service Policy and Planning Regent Road EDINBURGH EH1 3DG Dear Colleague GENERAL DENTAL SERVICES
More informationInformation Technology Solutions
Information Technology Solutions World Institute of Pain (WIP) Excellence in Pain Practice Award Award Applicant Site Inspection Handbook June 28, 2010 WIP EPP Award Site Inspection Handbook Page 2 Table
More informationNIIM HREC: TGA AUTHORISED PRESCRIBER SCHEME APPLICATION APPROVAL PROCEDURES 1. Procedures Statement
NIIM HREC: TGA AUTHORISED PRESCRIBER SCHEME APPLICATION APPROVAL PROCEDURES 1. Procedures Statement The aim of these procedures is to set out the processes for applications to the NIIM Human Research Ethics
More informationPIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 040-1 3 Appendices 1 January 2019 PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES PIC/S January 2019 Reproduction
More informationPOLICIES GOVERNING PROCEDURES FOR THE USE OF ANIMALS IN RESEARCH AND TEACHING AT WESTERN WASHINGTON UNIVERSITY and REVIEW OF HUMAN SUBJECT RESEARCH
Appendix 9 POLICIES GOVERNING PROCEDURES FOR THE USE OF ANIMALS IN RESEARCH AND TEACHING AT WESTERN WASHINGTON UNIVERSITY and REVIEW OF HUMAN SUBJECT RESEARCH INTRODUCTION It is the policy of Western Washington
More informationCHAPTER 4 POST-MARKETING SURVEILLANCE OF DRUGS
CHAPTER 4 POST-MARKETING SURVEILLANCE OF DRUGS Post-marketing surveillance (PMS) to assure the quality, efficacy and safety of drugs after they go on the market and to establish proper methods of use of
More informationSALISBURY UNIVERSITY COMMITTEE ON HUMAN RESEARCH APPLICATION FOR RESEARCH INVOLVING HUMAN SUBJECTS
SALISBURY UNIVERSITY COMMITTEE ON HUMAN RESEARCH APPLICATION FOR RESEARCH INVOLVING HUMAN SUBJECTS If you have a full committee review: 1. Your proposal must be submitted at minimum 14 days before the
More informationSECTION PRESCRIPTIONS
SECTION.1800 - PRESCRIPTIONS 21 NCAC 46.1801 EXERCISE OF PROFESSIONAL JUDGMENT IN FILLING PRESCRIPTIONS (a) A pharmacist or device and medical equipment dispenser shall have a right to refuse to fill or
More informationPolicy / Drug and Alcohol-Free Workshops
Policy 4118.235/4218.235 Drug and Alcohol-Free Workshops DATE: February 13, 2017 PREVIOUS ITEM: None ENCLOSURES: CABE s Suggested Policy 4118.235/4218.235 CABE s July 15, 2016 Policy Update REASON: To
More informationQuality, Safety and Sourcing in Unlicensed Medicines
Quality, Safety and Sourcing in Unlicensed Medicines with Andrew Trouton Managing Director, UL Medicines Agenda Welcome What is an unlicensed medicine? When should you consider using an unlicensed medicine?
More informationMC IRB Protocol No.:
APPLICATION FORM - INITIAL REVIEW INSTITUTIONAL REVIEW BOARD Room 117 Main Building 555 Broadway Dobbs Ferry NY 10522 Phone: 914-674-7814 / Fax: 914-674-7840 / mcirb@mercy.edu MC IRB Protocol No.: Date
More informationOECD GUIDELINE FOR TESTING OF CHEMICALS. Proposal for a New DRAFT GUIDELINE 434: Acute Dermal Toxicity Fixed Dose Procedure
OECD GUIDELINE FOR TESTING OF CHEMICLS Proposal for a New DRFT GUIDELINE 434: cute Dermal Toxicity Fixed Dose Procedure DRFT GUIDELINE INTRODUCTION 1. OECD Guidelines for the Testing of Chemicals are periodically
More informationExcipient Risk Assessment
Excipient Risk Assessment Richard O Sullivan- GMP Inspector GMP Conference 7 February 2017 Dublin Content Background 1 Guidance 2 HPRA Expectations 3 07/02/2017 2 Excipient Risk Assessment-Why? 07/02/2017
More informationAGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)
AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred
More informationProcedure. Identify all possible radiation hazards.
Guidance Notes on Radiation Risk Assessment Prior to commencing any new work practice involving a source of ionising radiation it is important that a realistic assessment of the radiation risks is carried
More informationIAEA-TECDOC-895. Application of quality assurance to radioactive waste. disposal facilities INTERNATIONAL ATOMIC ENERGY AGENCY
IAEA-TECDOC-895 Application of quality assurance to radioactive waste disposal facilities INTERNATIONAL ATOMIC ENERGY AGENCY August 1996 The IAEA does not normally maintain stocks of reports in this series.
More informationDraft Guidance for Pharmacists on Extemporaneous Dispensing. Version 1
1. Introduction Draft Guidance for Pharmacists on Extemporaneous Dispensing Version 1 The purpose of this guidance is to assist pharmacists in discharging their legal and professional obligations to patients
More informationSandoz Inc. 12-Aug-08
Sandoz Inc. 12-Aug-08 Department of Health and Human Services Public Health Service Food and Drug Administration Atlanta District Office 60 8th Street, N.E. Atlanta, Georgia 30309 August 12, 2008 VIA FEDERAL
More informationAnimal health requirements for heat-processed poultry meat and meat products. to be exported from Russian Federation to Japan.
Animal health requirements for heat-processed poultry meat Animal health requirements for heat-processed poultry meat and meat products to be exported from Russian Federation to 1. This document defines
More informationNew Drugs Division. Frequently Asked Questions (FAQs) on Approval of new Phytopharmaceutical Drugs
Central Drugs Standard Control Organization Directorate General of Health Services Ministry of Health and Family Welfare Government of India New Drugs Division Frequently Asked Questions (FAQs) on Approval
More informationMedidée Services SA. Nano-Tera.ch. 05 February 2015 part 4. Intro ISO GMP - GLP Pierre-Alain Sommer
Nano-Tera.ch 05 February 2015 part 4 Intro ISO GMP - GLP Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 Introduction to ISO 13485, cgmp s and GLP s Context
More informationDIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004
30.4.2004 Official Journal of the European Union L 136/85 DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 amending, as regards traditional herbal medicinal products,
More informationGPS Product Safety Summary
Document Number: GPSSR 20 15 MAGNESIUM CHLORIDE GENERAL STATEMENT GPS summary is intended to provide a general overview of the chemical substances in context of ICCA Global Product Strategy. The information
More informationLast Name First name Academic degrees. Professional titles and/or work position within your home institution
Date received stamp ETHICS AND RESEARCH APPLICATION FORM Kenyatta National Hospital/University of Nairobi KEMRI CENTERS ETHICS RESEARCH COMMITTEE Application Number Submit three copies of this form (including
More informationYes or No. Yes or No. Yes or No. Yes or No. Yes or No
NYS Nutrition for the Elderly Program Check Sheet For MLTC Plans with SADS Contracts in NYC Requirement Service Delivery Policy and Procedures -Section on Nutrition SADS: Date: Documentation Policy and
More informationOECD/OCDE 245 Adopted: 9 October 2017
Adopted: 9 October 2017 OECD GUIDELINE FOR THE TESTING OF CHEMICALS HONEY BEE (APIS MELLIFERA L.), CHRONIC ORAL TOXICITY TEST (10-DAY FEEDING) INTRODUCTION 1. This Test Guideline describes a chronic oral
More informationREPORT FOR HUMAN CLINICAL TRIAL PHASE III TO STUDY THE SAFETY AND EFFECTIVENESS OF OXY-POWDER
1 VERSION 01 REPORT FOR HUMAN CLINICAL TRIAL PHASE III TO STUDY THE SAFETY AND EFFECTIVENESS OF OXY-POWDER DOCUMENT NO.: MCERC/REPT-CLTR/OXY/1205/001 May 30 th 2007 TRIAL TO STUDY THE SAFETY AND EFFECTIVENESS
More informationBRANZ Type Test FH 5070-TT [2014]
1222 Moonshine Road Judgeford RD1 Porirua 5381 New Zealand T +64 4 237 1170 F +64 4 237 1171 branz@branz.co.nz www.branz.co.nz BRANZ Type Test FH 5070-TT [2014] CONE CALORIMETER TEST AND NZBC VERIFICATION
More informationHealthcare (clinical) Waste Awareness
Healthcare (clinical) Waste Awareness Disposal of Dental Service Waste Dental services in NHS Boards, where applicable, can now use the healthcare (clinical) waste service provided by the NHS Board for
More informationMRI Unit The University of Hong Kong. Guidelines on Animal Studies
MRI Unit Tel: (852) 2817 0373 Fax: (852) 2817 4013 Guidelines on Animal Studies General principles 1. The MRI Unit may be used by HKU researchers for animal studies with prior approval by the Scientific
More informationDistillers Grains Symposium
Distillers Grains Symposium REGULATORY ISSUES/FSMA IMPACTS ON PRODUCTION & SALE OF DDGS Leah Wilkinson American Feed Industry Association lwilkinson@afia.org Dallas, TX May 15, 2014 Topics to be Presented
More informationBRANZ Type Test FH 5557-TT [2014]
1222 Moonshine Road Judgeford RD1 Porirua 5381 New Zealand T +64 4 237 1170 F +64 4 237 1171 branz@branz.co.nz www.branz.co.nz BRANZ Type Test FH 5557-TT [2014] CONE CALORIMETER TEST AND NZBC VERIFICATION
More informationSOUTH DAKOTA BOARD OF REGENTS. Policy Manual
SUBJECT: Drug Free Environment NUMBER: 4:27 SOUTH DAKOTA BOARD OF REGENTS Policy Manual Drug Free Workplace Policy The South Dakota Board of Regents is committed to providing a drug free workplace. Additional
More informationTest Report. No. CANEC Date: 05 Jan Page 1 of 7. (SVHC)
Test Report. No. CANEC1522020801 Date: 05 Jan 2016. Page 1 of 7. YUNNAN TIN CO.,LTD.. 49#MIDDLE OF CHANGYUAN ROAD,KUNMING NATIONAL HIGH&NEW TECH INDUSTRY DEVELOPMENT ZONE,KUNMING,YUNNAN CHINA.. The following
More informationGuideline on the demonstration of palatability of veterinary medicinal products
10 July 2014 EMA/CVMP/EWP/206024/2011 Committee for Medicinal Products for Veterinary Use (CVMP) Guideline on the demonstration of palatability of veterinary medicinal products Draft agreed by Efficacy
More informationJuly 27-30, th Annual Meeting of the Poultry Science Association Louisville, Kentucky. Presented at:
July 27-30, 2015 104 th Annual Meeting of the Poultry Science Association Louisville, Kentucky Presented at: From Egg to Plate The Influence of Gut Health Symposium Presentations distributed by DuPont
More informationNon-destructive testing Penetrant testing. Part 2: Testing of penetrant materials
Provläsningsexemplar / Preview INTERNATIONAL STANDARD ISO 3452-2 Third edition 2013-11-15 Non-destructive testing Penetrant testing Part 2: Testing of penetrant materials Essais non destructifs Examen
More informationNA-019 LEVEL 3 QUALIFICATION RECOGNITION FOR AS3669 AND EN 4179 / NAS 410
NA-019 LEVEL 3 QUALIFICATION RECOGNITION FOR AS3669 AND EN 4179 / NAS 410 Initial Qualification Recognition This procedure describes how the NANDTB recognises NDT Level 3 personnel qualifications as meeting
More information4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch
Libia Lugo Drug Specialist San Juan District Office Investigations Branch The Food and Drug Administration (FDA) responsibilities extend to the 50 United States, the District of Columbia, Puerto Rico,
More informationHSPC/IRB Description of Research Form (For research projects involving human participants)
HSPC/IRB Description of Research Form (For research projects involving human participants) This form is to be completed by the Principal Investigator (P.I.) of the research project being submitted to the
More informationDeveloped By Name Signature Date
Patient Group Direction 2155 version 2.0 Administration / Supply of Inhaled Salbutamol in Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Trust Date of Introduction:
More informationTENNESSEE STATE UNIVERSITY HUMAN SUBJECTS COMMITTEE
TENNESSEE STATE UNIVERSITY HUMAN SUBJECTS COMMITTEE RESEARCH PROPOSAL FORM This proposal is: (check where applicable) Dissertation Research: Grant Proposal: Funding Agency: Master's Thesis Research: Faculty
More informationGuide to Registration of Homeopathic Veterinary Medicinal Products
Guide to Registration of Homeopathic Veterinary Medicinal Products AUT-G0047-3 16 NOVEMBER 2012 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes
More informationTest Report. No. SHAEC Date: 12 Sep Page 1 of 6. (SVHC)
Test Report. No. SHAEC1405830702 Date: 12 Sep 2014. Page 1 of 6. TOPDIODE MANUFACTURING COMPANY LIMITED. SHANGKENG INDUSTRIAL ROAD NO.3,SHANGKENG INDUSTRIAL PARK,CHANGPING TOWN,DONGGUAN,GUANGDONG,CHINA..
More informationGUIDE TO THE APPLICATION TO POSSESS AND USE A SOURCE(S) FOR INDUSTRIAL APPLICATIONS
ATOMIC ENERGY COUNCIL GUIDE TO THE APPLICATION TO POSSESS AND USE A SOURCE(S) FOR INDUSTRIAL APPLICATIONS Item Type of Application 1 Name and address of applicant 2 Radiation safety Officer (RSO) Guiding
More information